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STflTUS OF THE ENVIRONfTlENTflL PROTECTION AGENCY'S REVIEW OF
RODENTICIDES
WILLIflfTl C. DICKINSON, Deputy Director, Special Pesticide Review Division, Office of
Pesticide Programs, U.S. Environmental Protection Agency, 401 IT) Street, S.W.,
Washington, D.C. 2O46O
ABSTRACT: The EPA is currently conducting RPAR reviews on two widely used
rodenticides, strychnine and Compound 1080. In addition, Registration Stan-
dards have been developed for the rodenticides warfarin and Fumarin®. The
Zinc Phosphide Standard is currently under development. The author briefly
explains the factors the Agency has been taking into account in reaching final
resolution on these chemicals as well as outlining EPA's reregistration and
RPAR programs.
I have been asked to speak to you this morning to provide a status on
three rodenticides which are currently under review by the Environmental Pro-
tection Agency. These are strychnine, Compound 1080 (rodenticide uses only)
and zinc phosphide. The rodenticide uses of 1080 and strychnine are being
studied because of the Rebuttable Presumptions Against Registration (RPARs)
issued on December 1, 19761, and January 13, 19772 respectively. Zinc
phosphide is being reviewed for the development of a Registration Standard
which is part of EPA's reregistration program. Since all three are used as
an acute toxicant for many of the same target animals and are therefore alter-
natives to one another, the Agency is conducting all three reviews simulta-
neously. Registration Standards for two other widely used rodenticides,
FumarinEPand warfarin1* and one bird repellent, 4-Aminopyridine5, have already
been issued. The RPARs for strychnine and Compound 1080 were issued because
of the risk to nontarget birds and animals, including endangered species.
The determination that the two rodenticides should be thoroughly investigated
was based largely on laboratory LD50 values and on observations that nontarget
animals could be at risk both from primary and secondary poisoning.6
Ml FR 52792 (12/1/76): copies of the Position Documents 1 are available from
the National Technical Information Service (NTIS), U.S. Department of Com-
merce, 5282 Port Royal Road, Springfield, Virginia 22161; Document
#PB 80 216823
242 FR 2713 (1/13/77); NTIS #PB 80 216807
'September, 1980; NTIS #PB 81 12812
^Copies of the Warfarin Registration Standard are expected in October 1981
and will be available from NTIS.
September, 1980; NTIS #5AD/RS 81-00380
6Definitions of the risk cr i ter ia that, when met or exceeded, can trigger
RPAR analyses can be found in the Federal Register of July 3, 1975 (40 CFR
162.11). These risk cri teria are concerned with the following areas:
1. Acute Toxicity
2. Chronic Toxicity
(continued on next page)
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Both processes, the RPAR and Registration Standards, involve a search for
and evaluation of any and all relevant literature and studies. The output of
the RPAR process is a set of proposed actions covering each currently regis-
tered use of the chemical. The output of the Registration Standard process is
a set of criteria that define the conditions under which any pesticide con-
taining the chemical under investigation as an active ingredient will be
registered or reregistered. This includes a complete identification of "gaps"
in the supporting scientific data. Registrants must commit to fill these gaps
and make necessary label revisions before reregistration can occur.
The primary difference in the two processes is that in the case of the
RPARs, the Agency believes that an unreasonable adverse effect to man or the
environment is posed by the continued use of the chemical. Therefore, a
detailed use-by-use risk/benefit analysis is undertaken and this becomes
central to the decision making process. In developing a Registration Standard,
a process the Agency will eventually go through for the active ingredients of
all pesticides, there is no known information suggesting an unreasonable
adverse effect as the Standard is developed. The Standard does not undertake
an explicit risk/benefit analysis, unless of course data are discovered sug-
gesting unreasonable adverse effects. The intent of the reregistration effort
is to ensure the safety of existing pesticides and to expedite future Agency
registration actions on these compounds.
In the case of the strychnine RPAR, the benefits have been defined as
the increased cost of providing an equal level of control using alternative
methods. Reregistration or registration of a chemical for a particular use
will be allowed only if the benefits exceed the risks. This may involve
maintaining the status quo or adopting certain risk reduction measures. If
measures are not available or feasible such that the risks can be reduced to
the point where they are exceeded by the benefits, cancellation may be proposed.
In the case of the rodenticidal uses of strychnine, four criteria were
followed in developing and evaluating our regulatory options.
1. The ability to control each target rodent species was not to be taken
away if at all possible.
2. The proposed actions are determined by the existence of risks, not
the absence of benefits.
3. The use of an alternative method of rodent control must not increase
the risk related to the benefits.
A. Oncogenic
B. Mutagenic
Other Chronic Effects
A. Reproductive
(1) Fetotoxicity
(2) Teratogenicity
B. Spermatogenicity
C. Testicular Effects
D. Neurotoxicity
E. Others
Significant reduction in wildlife, reduction in endangered species,
and reduction in nontarget species.
Lack of emergency treatment or antidote.
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4. Any proposed risk mitigating and risk reducing measures, including
the use of alternatives, must be economically feasible and viable.
The basis for the f i r s t c r i te r ion , retaining the ab i l i t y to control the
target rodent pest, arose from an examination of the rebuttals to the RPAR
notice and a detailed benefit analysis. Although accurate figures were not
provided for the amount and value of cropland, rangeland and non-agricultural
si te damage caused by birds and animals, the comments and analysis made the
need for some controls obvious.
For some uses of strychnine the relat ively small amount of bait used and
the absence of any figures showing damage prevention meant that the benefits
might be considered as negligible. The small amount of usage also implies,
however, l i t t l e potential for exposure and, therefore, l i t t l e potential for
r isk. In the absence of data, def in i te , quantifiable comparisons were not
possible. This need for a qual i tat ive analysis formed the basis for the
second c r i te r ion , that an absence of measurable benefits was not grounds for
a proposed action.
Because an RPAR is an intensive examination of the risks and benefits of
some or a l l uses of a single pesticide, the focus of the examination is such
that the risks and benefits of alternatives are presented mainly as comparisons
to the subject chemical. As mentioned ear l ier , the benefits of strychnine
were presented as the increased costs of using alternatives. Similarly, the
risks of alternatives were presented as being either greater than, equal to,
or less than the chemical under investigation. In some cases, rough quanti-
tat ive comparisons were possible, but in most instances, the relationships
were qual i tat ive. The purpose of the type of analysis is simply to help form
a basis for developing and evaluating possible regulatory options. From this
analysis, the Agency is able to predict whether an alternative is worse than
the chemical being studied, in keeping with the th i rd c r i te r ion.
Having determined that the ab i l i t y to control target pests was not to be
taken away, the Agency's proposed actions attempt to ensure that de facto
cancellation does not occur. This de facto cancellation would arise i f the
alternative or use modification were too expensive to use or i f no one would
use the chemical because the restr ict ions on the use were just too much
trouble, or v i r tua l l y impossible to comply with. For these reasons, the
Agency established the fourth c r i te r ion , that the proposed action had to be
economically feasible and viable.
What were the Agency's main concerns after analyzing the risks and bene-
f i t s of strychnine and the alternatives? We were concerned that we lacked
data as to whether the proposed risk reduction measures would lessen the
efficacy of the pesticide. We were concerned with the lack of quantitative
data on benefits and r isks. We were especially concerned as to whether our
actions would comply with the Endangered Species Act.
In the ideal s i tuat ion, jus t the r ight amount of bait with just the r ight
active ingredient concentration is distributed in a way that a l l the bait is
eaten by the target pests and that the animal consumes no more active ingre-
dient than is absolutely necessary to k i l l i t . I f this happens, no risk of
primary poisoning of nontarget animals would be possible and the risk of
secondary poisoning would be minimized.
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Unfortunately, in our investigation we could not find any data that we
could use to establish the lowest efficacious active ingredient concentration
and dosage combination for strychnine. The option the Agency chose in the
case of strychnine was to try to elicit information from users and registrants
to try to come as close as possible to the optimum of the lowest efficacious
level. In the case of strychnine we selected from the myriad of currently
registered labels the one with the lowest active ingredient concentration.
Parenthetically, for compound 1080, the range of concentrations on the regis-
tered labels is not as great as with strychnine.
The important point is that, in the case of strychnine, our goal was to
obtain data, regardless of the format, that would help us come as close as
possible to the lowest efficacious level. At this point, our actions are only
proposed and we are willing to alter our decisions if we are given data showing
that the proposed levels will not be efficacious.
The other use modifications that concerned us were those that were de-
signed to protect endangered species. Although the purpose of the RPAR was
to determine if strychnine could continue to be used without killing nontarget
animals, we realized that without cancellation, some nontarget kills are
inevitable. We concluded that, given the benefits, these nontarget kills were
acceptable as long as the numbers were minimized. This decision did not apply
to endangered species.
Our goal is to allow the use of strychnine while precluding the possibil-
ity of jeopardizing the existance of an entire endangered species. Obviously,
the easiest way to insure this is through a cancellation. However if the use
is only prohibited in those areas where endangered species exist, the major
uses could continue with only geographical restrictions. The problem was to
prohibit the use in a manner that was both enforceable and realistic. In some
cases, the ranges of these species are rather well defined, but not in terms
of political boundaries. In other cases, the ranges were either not well
defined or were not known.
In an effort to elicit more precise information and to establish a start-
ing point for discussion, we proposed in the case of strychnine a prohibition
of use in those counties that encompassed the ranges of the endangered species.
This philosophy included the black-footed ferret, but, since the ferret could
be in any county that contains prairie dogs, we proposed cancellation for
prairie dog control.
What did we ultimately propose for strychnine? We retained all major
uses and standardized the labels. We proposed cancellation of the minor uses
and the use of strychnine for prairie dog control. We proposed geographically
restricted use if endangered species are jeopardized. These are all proposed
actions which were scrutinized by our scientific advisory panel in a public
meeting and on which many of you have commented. We are now looking carefully
at all these comments before reaching a final decision.
I have focused primarily on strychnine since the Agency has already set
forth its proposed action in September 1980. The proposed action (PD 2/3) on
Compound 1080 for rodent control uses has not yet been issued although the
analysis and regulatory options are currently in final internal Agency review.
However, much of what we learned in the strychnine proceedings will be
applicable to the 1080 (rodenticide uses) RPAR. There is considerable
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interest in any action the Agency might take on any of these materials and we
have received much comment including some intriging possibilities for resolu-
tion short of cancellation. One of these that will be of major consideration
in the final strychnine decision is the use of a precontrol survey of the area
in which the material is to be used to check for the existence of endangered
species.
An additional range of possibilities short of cancellation is available
to the Agency given the fact that the Federally registered uses of all three
rodenticides are classified for restricted use and that the states and other
governmental institutions exercise oversight in the use of these materials.
Further, these persons, typically professionals by training and experience,
are available to consult with the users in any additional use restrictions
which might be imposed on these materials. These professionals are quite
aware of the acute toxicity to humans presented by these materials and know
of the problems which would occur to nontarget animals and birds if the label
restrictions are not carefully adhered to.
The availability of zinc phosphide will be very important in our decision-
making for Compound 1080 as it was for strychnine, particularly for the prairie
dog control use. Some comments received as part of the strychnine RPAR have
addressed the efficacy and cost of zinc phosphide. These questions will have
to be addressed in relative terms, compared to strychnine and Compound 1080.
As I stated at the beginning, zinc phosphide is in the Registration
Standard process. The review and evaluation of all relevant studies and papers
has been completed, and we are in the process of deciding what conclusions can
be drawn and if additional studies are needed, The question of efficacy is
not a part of this registration standard. The information that we will obtain
from the intensive review of the zinc phosphide literature will be related
only to the risks. This information combined with the information in the
comments on strychnine and Compound 1080 will give as complete a risk/benefit
picture for zinc phosphide as possible.
The strychnine position document was for a proposed action, and once
required comments are received, we will finish preparation of the final posi-
tion document. The rodenticide 1080 PD 2/3 has not yet been issued but when
it is, it will be for a proposed action and comments will be solicited.7 The
thoroughness and equity of the Agency's final decision will be highly dependent
on the comments we receive from persons like yourselves who are practitioners
in animal control. I assure you that the Agency wants and needs any data you
can provide including your reaction to the viability of our proposed regulatory
actions. It is people like yourselves who use these materials and know what
is and is not practical in a field situation.
In the beginning, I said that all three rodenticides had to be considered
together, and that to ignore one would not give a complete picture. The
decision that the Agency will make will also have three elements, none of which
can be ignored -- data, timing and viable regulatory actions.
7When issued the proposed decision will be published in the Federal Register.
A limited number of copies of the supporting document will be available and
can be obtained by writing: Director, Special Pesticide Review Division,
U.S. Environmental Protection Agency, 401 M Street, S.W., Washington, D.C.
20460. A status report on all RPAR and Registration Standards is issued
periodically and may be obtained by writing to the above address.
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